Stefanini, B., Fulgenzi, C., Scheiner, B., Korolewicz, J., Cheon, J., Nishida, N., Ang, C., Marron, T., Wu, Y. L., Saeed, A., Wietharn, B., Rimassa, L., Pirozzi, A., Cammarota, A., Pressiani, T., Pinter, M., Balcar, L., Huang, Y.-H., Mehan, A., … D’Alessio, A. (2025). ALBI Grade Enables Risk Stratification for Bleeding Events and Refines Prognostic Prediction in Advanced HCC Following Atezolizumab and Bevacizumab. Journal of Hepatocellular Carcinoma, Volume 12, 671–683. https://doi.org/10.2147/jhc.s462701